These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9378199)

  • 1. [Long-term captopril therapy in asymptomatic patients with severe chronic aortic insufficiency].
    Bisignani G; Serafini O; Caporale R; Guzzo D; Plastina F
    G Ital Cardiol; 1997 Sep; 27(9):925-30. PubMed ID: 9378199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation.
    Schön HR
    J Hypertens Suppl; 1994 Jul; 12(4):S95-104. PubMed ID: 7965280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation.
    Schön HR; Dorn R; Barthel P; Schömig A
    J Heart Valve Dis; 1994 Sep; 3(5):500-9. PubMed ID: 8000584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term vasodilator therapy in patients with severe aortic regurgitation.
    Evangelista A; Tornos P; Sambola A; Permanyer-Miralda G; Soler-Soler J
    N Engl J Med; 2005 Sep; 353(13):1342-9. PubMed ID: 16192479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term evaluation of captopril in patients with chronic left sided valvular regurgitations.
    Jirasirirojanakorn K; Mahanonda N; Jootar P; Chaithiraphan S; Wansanit K; Watanaprakarnchai W
    J Med Assoc Thai; 1998 Jan; 81(1):1-9. PubMed ID: 9470315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function.
    Scognamiglio R; Rahimtoola SH; Fasoli G; Nistri S; Dalla Volta S
    N Engl J Med; 1994 Sep; 331(11):689-94. PubMed ID: 8058074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Captopril or nifedipine? Comparison of rest and exercise acute effects and long-term therapy in chronic isolated asymptomatic moderate to severe aortic regurgitation.
    Banaszewski M; Rydlewska-Sadowska W; Rubkiewicz S
    J Heart Valve Dis; 1998 Sep; 7(5):488-99. PubMed ID: 9793844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The best of valvular heart disease in 2006].
    de Gevigney G;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation.
    Plante E; Gaudreau M; Lachance D; Drolet MC; Roussel E; Gauthier C; Lapointe E; Arsenault M; Couet J
    Can J Physiol Pharmacol; 2004 Mar; 82(3):191-9. PubMed ID: 15052285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular remodeling after pulmonary autograft replacement of the aortic valve (Ross operation).
    Legarra JJ; Concha M; Casares J; Merino C; Muñoz I; Alados P
    J Heart Valve Dis; 2001 Jan; 10(1):43-8. PubMed ID: 11206767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of systolic hypertension on asymptomatic patients with chronic severe aortic regurgitation and initially normal left ventricular performance at rest.
    Supino PG; Borer JS; Herrold EM; Hochreiter CA; Preibisz J; Schuleri K; Roman MJ; Kligfield P
    Am J Cardiol; 2005 Oct; 96(7):964-70. PubMed ID: 16188525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation.
    Plante E; Lachance D; Beaudoin J; Champetier S; Roussel E; Arsenault M; Couet J
    Circ Heart Fail; 2009 Jan; 2(1):25-32. PubMed ID: 19808312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinapril therapy in patients with chronic mitral regurgitation.
    Schön HR; Schröter G; Barthel P; Schömig A
    J Heart Valve Dis; 1994 May; 3(3):303-12. PubMed ID: 8087269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves.
    Levine HJ; Gaasch WH
    J Am Coll Cardiol; 1996 Nov; 28(5):1083-91. PubMed ID: 8890799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship between left ventricular function and the precipitation of symptoms in severe chronic aortic insufficiency].
    Tarasoutchi F; Grinberg M; Parga Filho J; Cardoso LF; Izaki M; Lavítola P; Cardoso RH; da Luz PL; Bellotti G
    Arq Bras Cardiol; 1995 Apr; 64(4):301-9. PubMed ID: 7495386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial long-term effects of hydralazine in aortic regurgitation.
    Dumesnil JG; Tran K; Dagenais GR
    Arch Intern Med; 1990 Apr; 150(4):757-60. PubMed ID: 2327837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implication of valvular lesion and left ventricular size in asymptomatic patients with chronic organic mitral regurgitation and normal left ventricular performance.
    Krauss J; Pizarro R; Oberti PF; Falconi M; Cagide A
    Am Heart J; 2006 Nov; 152(5):1004.e1-8. PubMed ID: 17070180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in left ventricular function and mass during serial investigations after valve replacement for aortic stenosis.
    Lund O; Erlandsen M
    J Heart Valve Dis; 2000 Jul; 9(4):583-93. PubMed ID: 10947054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of 1-year captopril therapy in children with chronic aortic regurgitation who have no symptoms.
    Alehan D; Ozkutlu S
    Am Heart J; 1998 Apr; 135(4):598-603. PubMed ID: 9539473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortic valve replacement: a safe and durable option in patients with impaired left ventricular systolic function.
    Chukwuemeka A; Rao V; Armstrong S; Ivanov J; David T
    Eur J Cardiothorac Surg; 2006 Feb; 29(2):133-8. PubMed ID: 16386914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.